These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26463831)

  • 1. Studies Identify Non-Hodgkin Lymphoma Suppressor.
    Cancer Discov; 2015 Dec; 5(12):OF6. PubMed ID: 26463831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.
    Song L; Zlobin A; Ghoshal P; Zhang Q; Houde C; Weijzen S; Jiang Q; Nacheva E; Yagan D; Davis E; Galiegue-Zouitina S; Catovsky D; Grogan T; Fisher RI; Miele L; Coignet LJ
    Cancer Res; 2005 Jun; 65(11):4554-61. PubMed ID: 15930272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
    Ortega-Molina A; Boss IW; Canela A; Pan H; Jiang Y; Zhao C; Jiang M; Hu D; Agirre X; Niesvizky I; Lee JE; Chen HT; Ennishi D; Scott DW; Mottok A; Hother C; Liu S; Cao XJ; Tam W; Shaknovich R; Garcia BA; Gascoyne RD; Ge K; Shilatifard A; Elemento O; Nussenzweig A; Melnick AM; Wendel HG
    Nat Med; 2015 Oct; 21(10):1199-208. PubMed ID: 26366710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
    Morin RD; Mendez-Lago M; Mungall AJ; Goya R; Mungall KL; Corbett RD; Johnson NA; Severson TM; Chiu R; Field M; Jackman S; Krzywinski M; Scott DW; Trinh DL; Tamura-Wells J; Li S; Firme MR; Rogic S; Griffith M; Chan S; Yakovenko O; Meyer IM; Zhao EY; Smailus D; Moksa M; Chittaranjan S; Rimsza L; Brooks-Wilson A; Spinelli JJ; Ben-Neriah S; Meissner B; Woolcock B; Boyle M; McDonald H; Tam A; Zhao Y; Delaney A; Zeng T; Tse K; Butterfield Y; Birol I; Holt R; Schein J; Horsman DE; Moore R; Jones SJ; Connors JM; Hirst M; Gascoyne RD; Marra MA
    Nature; 2011 Jul; 476(7360):298-303. PubMed ID: 21796119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma.
    Almasmoum HA; Airhihen B; Seedhouse C; Winkler GS
    Leuk Lymphoma; 2021 Feb; 62(2):281-290. PubMed ID: 33021411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
    Ding B; Yan L; Zhang Y; Wang Z; Zhang Y; Xia D; Ye Z; Xu H
    FEBS Open Bio; 2019 Apr; 9(4):693-706. PubMed ID: 30984543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein.
    Gagrica S; Hauser S; Kolfschoten I; Osterloh L; Agami R; Gaubatz S
    EMBO J; 2004 Nov; 23(23):4627-38. PubMed ID: 15538385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.
    Zhang J; Dominguez-Sola D; Hussein S; Lee JE; Holmes AB; Bansal M; Vlasevska S; Mo T; Tang H; Basso K; Ge K; Dalla-Favera R; Pasqualucci L
    Nat Med; 2015 Oct; 21(10):1190-8. PubMed ID: 26366712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of BAALC in leukemogenesis.
    Heuser M; Berg T; Kuchenbauer F; Lai CK; Park G; Fung S; Lin G; Leung M; Krauter J; Ganser A; Humphries RK
    Leukemia; 2012 Mar; 26(3):532-6. PubMed ID: 21869843
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
    Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
    PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected].
    Haidar JH; Neiman RS; Orazi A; Albitar M; McCarthy LJ; Heerema N
    Mod Pathol; 1996 Apr; 9(4):355-9. PubMed ID: 8729971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetics and molecular genetics of non-Hodgkin's lymphoma].
    Mazur G; Haus O
    Pol Arch Med Wewn; 2002 Oct; 108(4):993-1000. PubMed ID: 12642946
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
    Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
    Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How important is ATM?
    Lavin MF
    Radiat Res; 2005 Jun; 163(6):704. PubMed ID: 16044504
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
    Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
    Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
    Ji MM; Huang YH; Huang JY; Wang ZF; Fu D; Liu H; Liu F; Leboeuf C; Wang L; Ye J; Lu YM; Janin A; Cheng S; Zhao WL
    Haematologica; 2018 Apr; 103(4):679-687. PubMed ID: 29305415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.